Aandeel GENIL GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Aandelen

GENIL

TREGENL00024

Beurs gesloten - Borsa Istanbul
Andere beurzen
 17:09:57 03-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
58,2 TRY +4,39% Intraday-grafiek van Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi +0,78% +24,15%
06/04 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023 CI
2023 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2023
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to FTSE All-World Index
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the First Quarter Ended March 31, 2022
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2021
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(IBSE:GENIL) added to S&P Global BMI Index
RS Research announced that it has received TRY 12 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, One Life Ventures GmbH, and other investor
Galventa announced that it has received €0.696 million in funding from Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
ARIAD Pharmaceuticals, Inc Announces Commercial Distribution Agreement with Gen Ilac for Iclusig(Ponatinib) in Turkey
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers GENIL
  4. Nieuws Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
  5. Andere talen